Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: UNIVERSITY OF OKLAHOMA
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2022-06-28 to 2022-12-27
Current total value of award: $139980
Description: BASE TITLE: PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE BIOMARKERS  TASK ORDER TITLE: PREVENTING FAP-CRC USING RLON PROTEASE IN PIRC RAT MODEL